Dinitrochlorobenzene therapy in alopecia areata.
With topical therapy using dinitrochlorobenzene (DNCB), 36 (72%) out of 50 patients having alopecia areata showed regrowth of hair in 3 to 6 months time. Five (10%) patients experienced marked vesiculation and severe contact dermatitis requiring cessation of therapy. In 7 (14%) patients there was no response at all and 4 (8%) presented with other side-effects.
Kalam
A
A
Department of Medicine (Skin and Venereal Diseases), JN Medical College, Aligarh Muslim University.
Tahseen
M D
MD
Islam
S F
SF
Rahmatullah
M D
MD
Faruqi
N A
NA
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D004137:Dinitrochlorobenzene